Quarterly report · Q2
4570.TEDINET S100PKP5
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥293m | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥648m | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥254m | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | −¥55m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | −¥137m | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | −¥130m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥243m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥188m | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥132m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥195m | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥136m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥259m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥199m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥136m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | −¥199m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥1.6bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥1.7bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥1.7bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥329m | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥337m | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.2bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥1.4bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.4bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥406m | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥508m | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥341m | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥449m | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥546m | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥552m | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥51m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥93m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥100m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥64m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥156m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥39m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥3m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥144m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥132m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-14.62 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.29 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-27.78 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-21.4 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-9.51 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 78.9% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.2% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.8% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 25
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E00986-000Cosmeticsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2m |
| jpcrp040300-q2r_E00986-000Cosmeticsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2m |
| jpcrp040300-q2r_E00986-000Cosmeticsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥8m |
| jpcrp040300-q2r_E00986-000Gene Recombination Silkworm Developmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥41m |
| jpcrp040300-q2r_E00986-000Immunity Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥291m |
| jpcrp040300-q2r_E00986-000Immunity Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥291m |
| jpcrp040300-q2r_E00986-000Immunity Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥6m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥293m |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥293m |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | −¥55m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥3m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥3m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | ¥480,000 |
| jpcrp040300-q2r_E00986-000Cosmeticsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥10m |
| jpcrp040300-q2r_E00986-000Cosmeticsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥10m |
| jpcrp040300-q2r_E00986-000Cosmeticsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | −¥5m |
| jpcrp040300-q2r_E00986-000Gene Recombination Silkworm Developmentreportable segment | segment profit | 2021-04-01 → 2021-09-30 | −¥53m |
| jpcrp040300-q2r_E00986-000Immunity Relatedreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥247m |
| jpcrp040300-q2r_E00986-000Immunity Relatedreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥244m |
| jpcrp040300-q2r_E00986-000Immunity Relatedreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥3m |
| jpcrp040300-q2r_E00986-000Immunity Relatedreportable segment | segment profit | 2021-04-01 → 2021-09-30 | −¥79m |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥257m |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥254m |
| —segment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥3m |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | −¥137m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 431
| Item | Context | Value | Unit |
|---|---|---|---|
| Liabilities and net assets | Prior1YearInstant | 1705338000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 1561617000 | JPY |
| Net sales | Prior1YTDDuration | 253993000 | JPY |
| Net sales | CurrentYTDDuration | 293166000 | JPY |
| Cost of sales | Prior1YTDDuration | 129204000 | JPY |
| Cost of sales | CurrentYTDDuration | 119966000 | JPY |
| Gross profit | Prior1YTDDuration | 124789000 | JPY |
| Gross profit | CurrentYTDDuration | 173199000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 261310000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 227761000 | JPY |
| Operating income | Prior1YTDDuration | -136520000 | JPY |
| Operating income | CurrentYTDDuration | -54561000 | JPY |
| Interest income noi | Prior1YTDDuration | 65000 | JPY |
| Interest income noi | CurrentYTDDuration | 630000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | － | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 8937000 | JPY |
| Insurance premiums refunded cancellation noi | Prior1YTDDuration | 3107000 | JPY |
| Insurance premiums refunded cancellation noi | CurrentYTDDuration | 4774000 | JPY |
| Other noi | Prior1YTDDuration | 2527000 | JPY |
| Other noi | CurrentYTDDuration | 1972000 | JPY |
| Non operating income | Prior1YTDDuration | 5700000 | JPY |
| Non operating income | CurrentYTDDuration | 16315000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 132000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 536000 | JPY |
| Foreign exchange losses noe | Prior1YTDDuration | 31000 | JPY |
| Foreign exchange losses noe | CurrentYTDDuration | － | JPY |
| Equity in losses of affiliates noe | Prior1YTDDuration | 57180000 | JPY |
| Equity in losses of affiliates noe | CurrentYTDDuration | 90359000 | JPY |
| Other noe | Prior1YTDDuration | 5000 | JPY |
| Other noe | CurrentYTDDuration | 526000 | JPY |
| Non operating expenses | Prior1YTDDuration | 57349000 | JPY |
| Non operating expenses | CurrentYTDDuration | 91421000 | JPY |
| Ordinary income | Prior1YTDDuration | -188170000 | JPY |
| Ordinary income | CurrentYTDDuration | -129668000 | JPY |
| Loss on valuation of investment securities el | Prior1YTDDuration | － | JPY |
| Loss on valuation of investment securities el | CurrentYTDDuration | 1108000 | JPY |
| Impairment loss el | Prior1YTDDuration | 7041000 | JPY |
| Impairment loss el | CurrentYTDDuration | 804000 | JPY |
| Extraordinary loss | Prior1YTDDuration | 7041000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 1913000 | JPY |
| Income before income taxes | Prior1YTDDuration | -195211000 | JPY |
| Income before income taxes | CurrentYTDDuration | -131581000 | JPY |
| Income taxes current | Prior1YTDDuration | 4121000 | JPY |
| Income taxes current | CurrentYTDDuration | 4586000 | JPY |
| Income taxes | Prior1YTDDuration | 4121000 | JPY |
| Income taxes | CurrentYTDDuration | 4586000 | JPY |
| Profit loss | Prior1YTDDuration | -199333000 | JPY |
| Profit loss | CurrentYTDDuration | -136168000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | -199333000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | -136168000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |